Novartis is one of the leading pharmaceutical groups in Italy and, for more than 20 years, a major player in innovation in the area of healthcare.
With its activities focused on innovative medicines and equivalent and biosimilar drugs, it plays a leading role in all major therapeutic areas.
The Novartis Group also includes Advanced Accelerator Applications (AAA), a radiopharmaceutical company with a major presence in Italy, and Novartis Gene Therapies, an international company with a leading role in gene therapy.
In 2021, its turnover in Italy was €1,663.2 million (of which €64 million from exports; its investments amounted to more than €70 million, of which €60 million in R&D; Novartis employs 2,170 people in Italy.
